Intended for healthcare professionals

Letters Dental procedures, antibiotics, and infective endocarditis

Authors’ reply to Baker and Alderson

BMJ 2017; 359 doi: https://doi.org/10.1136/bmj.j4734 (Published 16 October 2017) Cite this as: BMJ 2017;359:j4734
  1. Thomas J Cahill, cardiology specialist registrar1,
  2. Mark Dayer, consultant cardiologist2,
  3. Bernard Prendergast, consultant cardiologist3,
  4. Martin Thornhill, professor of translational research in dentistry4
  1. 1Oxford Heart Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
  2. 2Department of Cardiology, Taunton and Somerset NHS Foundation Trust, Musgrove Park, Taunton, UK
  3. 3Department of Cardiology, Guy’s and St Thomas’ Hospitals NHS Foundation Trust, London, UK
  4. 4Department of Oral and Maxillofacial Medicine, Surgery and Pathology, University of Sheffield School of Clinical Dentistry, Sheffield, UK
  1. m.thornhill{at}sheffield.ac.uk

Baker and Alderson emphasise elements of the available data to support the decision made by NICE to withdraw antibiotic prophylaxis for patients at risk of infective endocarditis in the UK.1 Differing interpretations of best practice in the context of limited data are the essence of the uncertainty that underlies The BMJ’s article series and should be welcomed. As we outlined explicitly in our Uncertainties article,2 Baker and Alderson …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription